HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bin Han Selected Research

delphinidin 3-O-glucopyranoside

1/2016Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/HOTAIR signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bin Han Research Topics

Disease

58Neoplasms (Cancer)
08/2022 - 06/2010
16Inflammation (Inflammations)
11/2022 - 07/2009
11Carcinogenesis
06/2022 - 01/2016
11Infections
01/2021 - 03/2006
8Breast Neoplasms (Breast Cancer)
06/2022 - 01/2014
8Neoplasm Metastasis (Metastasis)
04/2021 - 01/2014
8Stroke (Strokes)
03/2021 - 03/2015
7Ischemic Stroke
11/2021 - 02/2016
7Prostatic Neoplasms (Prostate Cancer)
09/2020 - 01/2012
6Glioma (Gliomas)
04/2020 - 09/2011
6Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 10/2013
6Colonic Neoplasms (Colon Cancer)
09/2018 - 10/2013
5Cognitive Dysfunction
11/2020 - 10/2015
5Carcinoma (Carcinomatosis)
01/2020 - 05/2014
4Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 01/2020
4Fibrosis (Cirrhosis)
01/2021 - 11/2015
4Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 02/2016
4Stomach Neoplasms (Stomach Cancer)
06/2020 - 01/2018
3Intervertebral Disc Degeneration
10/2021 - 08/2008
2Spontaneous Abortion (Miscarriage)
07/2022 - 11/2020
2Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2021 - 01/2021
2Disease Resistance
01/2021 - 10/2015
2Esophageal Neoplasms (Esophageal Cancer)
10/2020 - 01/2020
2Osteoarthritis
09/2020 - 01/2019
2Colitis
05/2020 - 02/2018
2Cardiovascular Diseases (Cardiovascular Disease)
05/2020 - 07/2012
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2020 - 01/2016
2Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2020 - 01/2020
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 01/2020
2Body Weight (Weight, Body)
01/2020 - 01/2017
2Hyperuricemia
01/2020 - 07/2017
2Melanoma (Melanoma, Malignant)
01/2020 - 08/2018
2Diabetes Mellitus
01/2020 - 11/2017
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2019 - 01/2017
2Multiple Sclerosis
12/2019 - 01/2017
2Lung Neoplasms (Lung Cancer)
11/2019 - 11/2016
2Brain Ischemia (Cerebral Ischemia)
10/2019 - 06/2014
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 10/2012
2Chronic Renal Insufficiency
01/2019 - 11/2017

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2008
14MicroRNAs (MicroRNA)IBA
11/2021 - 09/2011
13Biomarkers (Surrogate Marker)IBA
07/2022 - 04/2011
10Particulate MatterIBA
07/2022 - 10/2016
9Anthocyanins (Anthocyanin)IBA
06/2022 - 01/2014
9Long Noncoding RNAIBA
08/2021 - 01/2016
9Biological ProductsIBA
01/2021 - 09/2011
6Therapeutic UsesIBA
10/2021 - 01/2016
6Messenger RNA (mRNA)IBA
01/2021 - 01/2013
5Interleukin-6 (Interleukin 6)IBA
07/2022 - 10/2013
5Pharmaceutical PreparationsIBA
06/2022 - 12/2010
5Circular RNAIBA
08/2021 - 01/2019
5Small Interfering RNA (siRNA)IBA
04/2021 - 06/2012
5CytokinesIBA
01/2021 - 01/2017
4delphinidinIBA
06/2022 - 01/2018
4NucleotidesIBA
01/2021 - 07/2006
4Transcription Factors (Transcription Factor)IBA
01/2020 - 12/2010
4SofosbuvirIBA
01/2019 - 12/2014
3Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2022 - 01/2019
3CateninsIBA
08/2021 - 01/2019
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 12/2010
3AntioxidantsIBA
11/2020 - 06/2014
3Cholinergic Agents (Cholinergics)IBA
10/2019 - 02/2017
3Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
04/2019 - 02/2014
3Mechanistic Target of Rapamycin Complex 1IBA
01/2019 - 10/2016
3EverolimusFDA Link
01/2019 - 10/2016
3Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
02/2018 - 01/2016
36-formylindolo(3,2-b)carbazoleIBA
02/2018 - 01/2016
3Uric Acid (Urate)IBA
07/2017 - 11/2015
3Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2015 - 06/2014
2AntigensIBA
08/2022 - 08/2018
2Phosphotransferases (Kinase)IBA
01/2021 - 03/2014
2N-methyladenosineIBA
01/2021 - 01/2020
2CollagenIBA
01/2021 - 01/2020
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020
2Malondialdehyde (Propanedial)IBA
11/2020 - 06/2014
2Antisense RNA (Anti-Sense RNA)IBA
04/2020 - 01/2016
2SootIBA
02/2020 - 01/2020
2InflammasomesIBA
02/2020 - 01/2020
2Indicators and Reagents (Reagents)IBA
01/2020 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 12/2010
2Caspase 3 (Caspase-3)IBA
01/2020 - 01/2020
2Androgen Receptors (Androgen Receptor)IBA
01/2020 - 01/2018
2Hydroxyproline (4 Hydroxyproline)IBA
01/2020 - 07/2011
2Neuroprotective AgentsIBA
01/2020 - 06/2014
2CarcinogensIBA
01/2020 - 01/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2019 - 06/2014
2Interleukin-17 (Interleukin 17)IBA
01/2019 - 11/2014

Therapy/Procedure

12Therapeutics
01/2021 - 06/2010
7Drug Therapy (Chemotherapy)
06/2022 - 10/2013
6Radiotherapy
01/2021 - 12/2013
4Thrombectomy
03/2021 - 12/2020
3Esophagectomy
10/2020 - 01/2020
3Transplantation
12/2016 - 08/2006
2Injections
10/2021 - 07/2017
2Airway Management
01/2021 - 01/2021
2Neoadjuvant Therapy
10/2020 - 01/2020
2Brachytherapy
09/2020 - 01/2020
2Immunotherapy
01/2020 - 01/2017
2Renal Dialysis (Hemodialysis)
01/2020 - 01/2010
2Analgesia
01/2019 - 01/2017